Chengdu Kanghong Pharmaceutical Group (002773.SZ) has obtained the registration certificate for Brivaracetam tablets.
Kanghong Pharmaceuticals (002773.SZ) announced that the company recently received the "Drug Registration Certificate" for brexpiprazole issued by the National Medical Products Administration (Certificate Number: 2025S03922, 2025S03923), approved for registration. The mechanism of action of brexpiprazole for treating schizophrenia is not yet clear, but it may be partially mediated through the partial agonist activity of serotonin 5-HT1A and dopamine D2 receptors, and the antagonist activity of serotonin 5-HT2A receptors.
Chengdu Kanghong Pharmaceutical Group (002773.SZ) announced that the company has recently received the "Drug Registration Certificate" for Brexpiprazole Tablets issued by the National Medical Products Administration (Certificate No: 2025S03922, 2025S03923), and it has been approved for registration. The mechanism of action of Brexpiprazole for the treatment of schizophrenia is not yet clear, but it may involve partial agonist activity at 5-HT1A and dopamine D2 receptors, as well as antagonist activity at 5-HT2A receptors.
Related Articles
Shengyi Electronics' shareholder Dongguan Science and Technology Investment Group has cumulatively reduced its stake in the company by 1%.
Guangdong Hec Technology Holding's subsidiary, Guangdong Hec Technology Holding Fluorine, intends to increase capital and expand its shareholding by introducing investors from Xingyin Investment.
Higa Co., Ltd. (603150.SH) intends to reduce its holdings by no more than 3% of its shares.
Shengyi Electronics' shareholder Dongguan Science and Technology Investment Group has cumulatively reduced its stake in the company by 1%.
Guangdong Hec Technology Holding's subsidiary, Guangdong Hec Technology Holding Fluorine, intends to increase capital and expand its shareholding by introducing investors from Xingyin Investment.
Higa Co., Ltd. (603150.SH) intends to reduce its holdings by no more than 3% of its shares.
RECOMMEND
